scholarly article | Q13442814 |
P50 | author | Julian Peto | Q6307461 |
Hoda Anton-Culver | Q28052887 | ||
Angela Cox | Q28484012 | ||
Anthony Swerdlow | Q60492223 | ||
Paul D P Pharoah | Q61822938 | ||
Fergus J. Couch | Q63018779 | ||
Christopher A. Haiman | Q73606228 | ||
Annegien Broeks | Q73632596 | ||
Maartje J. Hooning | Q74014444 | ||
Elinor J. Sawyer | Q74173254 | ||
Nick Orr | Q78318000 | ||
Les Robison | Q91435233 | ||
Peter Devilee | Q37361664 | ||
Joe Dennis | Q56875626 | ||
Douglas F. Easton | Q59812154 | ||
P2093 | author name string | Louise C Strong | |
Michael Hauptmann | |||
Hugoline G de Haan | |||
Rosie Cooke | |||
Smita Bhatia | |||
Flora E van Leeuwen | |||
Marjanka K Schmidt | |||
Marie L De Bruin | |||
Berthe M P Aleman | |||
Nicola S Russell | |||
Frederieke H van der Baan | |||
Anna M van Eggermond | |||
Augustinus D G Krol | |||
Cécile P M Janus | |||
Annemieke W J Opstal-van Winden | |||
P2860 | cites work | Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma | Q24632704 |
A global reference for human genetic variation | Q25909434 | ||
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood | Q28143725 | ||
Ageing or cancer: a review on the role of caretakers and gatekeepers | Q28244257 | ||
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists | Q28387859 | ||
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) | Q28943455 | ||
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. | Q31926021 | ||
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | Q33614244 | ||
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease | Q33773312 | ||
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists | Q33813463 | ||
Breast cancer after chest radiation therapy for childhood cancer | Q33910979 | ||
Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists | Q34070675 | ||
Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy | Q34250220 | ||
Power and predictive accuracy of polygenic risk scores. | Q34337027 | ||
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study | Q34477813 | ||
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group | Q34639851 | ||
Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies | Q72278250 | ||
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease | Q73155448 | ||
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors | Q74675998 | ||
Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study | Q80879443 | ||
p53-Dependent induction of PVT1 and miR-1204. | Q35709920 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York | Q36615332 | ||
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors | Q36924721 | ||
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists | Q36973531 | ||
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families | Q37131918 | ||
Radiation dose and breast cancer risk in the childhood cancer survivor study | Q37324982 | ||
Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists | Q37700040 | ||
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. | Q38410659 | ||
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma | Q38471731 | ||
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer | Q39844032 | ||
The identification of microRNAs in a genomically unstable region of human chromosome 8q24. | Q40006769 | ||
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure | Q40049393 | ||
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations | Q42628531 | ||
Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Q46103372 | ||
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | Q47190168 | ||
Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation | Q47225128 | ||
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study | Q47576468 | ||
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer | Q47601903 | ||
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group | Q47644209 | ||
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease | Q47788586 | ||
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. | Q51621180 | ||
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. | Q53241145 | ||
TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms. | Q53372775 | ||
Breast cancer after treatment of Hodgkin's disease. | Q53483025 | ||
Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3 | Q57202062 | ||
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists | Q57250667 | ||
Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic Technologists | Q57250681 | ||
FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma | Q57319538 | ||
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma | Q58410899 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
hematology | Q103824 | ||
Hodgkin lymphoma | Q209369 | ||
P304 | page(s) | 1130-1139 | |
P577 | publication date | 2019-03-07 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma | |
P478 | volume | 133 |
Search more.